Healthy volunteers
Conditions
Interventions
Trade Name: Echinaforce
Pharmaceutical Form: Oral drops*
Sponsors
Bioforce AG
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Age 18-65 Healthy ie. not taking medication such as antibiotics or antiviral therapy, herbal medicine, antidepressants or have recently received vaccination Participants who are not pregnant Participants who are not exposed to organic solvents Participants who have not undergone surgery within the last 3 months Participants who do not have an allergy to plants of the compositae family Participants who have not undertaken heavy, unusual physical activity 48 hours before first blood donation Participants who do not have a mild stress level as assessed by PSS-10 questionnaire Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Participants who are taking medication such as antibiotics or antiviral therapy, herbal medicine, antidepressants or have recently received vaccination Participants who are pregnant Participants who are exposed to organic solvents Participants who have undergone surgery within the last 3 months Participants who have an allergy to plants of the compositae family Participants who have undertaken heavy, unusual physical activity 48 hours before first blood donation Participants who have a mild stress level as assessed by PSS-10 questionnaire
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To observe the effects of an Echinacea preparation (Echinaforce®) on ex vivo stimulated blood cells obtained from healthy volunteers by measuring changes in concentrations of markers of inflammation and immune response before and after exposure to Echinacea.;Secondary Objective: Does the immune response of healthy volunteers exposed to Echinacea (Echinaforce®) differ between individuals.;Primary end point(s): Evidence that exposure to Echinacea provokes a stimulation of the immune system/response in healthy individuals | — |
Countries
United Kingdom
Outcome results
None listed